Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 288-657-1 | CAS number: 85857-16-5
Endpoint summary
Administrative data
Description of key information
In in vitro studies conducted according to OECD 439 and OECD 437, the substance was not irritating to skin or eyes (BSL Bioservice, 2014a, b and c).
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation:
A comparison has been made of the predictive powers for organosilicate substances of two reconstituted three-dimensional human skin models, EPISKIN-SM™ and EPIDERM, in OECD 439 studies. It has been concluded that one of the skin models tends to over predict skin irritation for these substances and the other tends to under predict. Therefore 2-(perfluorohexyl)ethyl]trimethoxysilane has been tested in both EPISKIN and EPIDERM. The results of both studies were negative, so it is concluded that the registered substance is not irritating to skin.
2-(perfluorohexyl)ethyl]trimethoxysilane has been tested in two reliable in vitro studies for skin irritation conducted according to OECD 439 and in compliance with GLP using EPISKIN-SM tissue (BSL Bioservice, 2014a) and EPIDERM (MatTek) (BSL Bioservice, 2014b). The mean tissue viability of the test-item treated tissues was not reduced relative to the negative controls in either tissue. The positive control produced the expected reduction in viability. It is concluded that the test item is not irritant under the conditions of the tests.
Eye irritation:
The eye irritancy potential of [2-(perfluorohexyl)ethyl]trimethoxysilane has been investigated in a valid in vitro bovine corneal opacity and permeability assay conducted in accordance with OECD 437 and in compliance with GLP (BSL Bioservice 2014c). The following mean in vitro irritation score was calculated: 0.27. The in vitro irritation score obtained with the positive control fell within the two standard deviations of the current historical mean and therefore this assay is considered to be valid. It is concluded that the test substance is not irritating to the eye.
Justification for classification or non-classification
Based on the available in vitro data [2-(perfluorohexyl)ethyl]trimethoxysilane does not require classification for skin or eye irritation according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
